It has been reported that pro-IL-16 undergoes cleavage into mature IL-16 by activated caspase-3 (ref. [34]), and previous reports indicate that inhibition of Aurora-A can activate caspase-3 in cancer cells (ref. [26]). The gene discussed is IL16; the disease is cancer.